Thanks to its original and innovative formula, it acts mechanically, exerting a protective mucoadhesive action, and promoting healing. It thus provides rapid relief from pain.
A NEW THERAPEUTIC APPROACH
Esoxx One combines the properties of chondroitin, hyaluronic acid and a polymer to adhere, relieve and promote healing of the esophageal mucosa
Poloxamer 407 is a polymer that has the property of exerting a thickening and gelling action thermoreversible, ie its texture varies with temperature. These specific properties allow it to form a macro-molecular complex with chondroitin and hyaluronic acid. This allows it to adhere to the mucosa, to exert a protective activity, but also to prolong the contact time and the duration of release of chondroitin and hyaluronic acid on the mucosal tissues.
Chondroitin is a fundamental component of the esophageal mucosa. It has an anti-inflammatory effect by stimulating the growth of fibroblasts. It also plays an important role in cell protection by reducing the proteolytic activity of pepsin. Thus, it relieves and prevents tissue damage
Hyaluronic acid, an essential component of epithelia, is a pivotal molecule in the healing process and plays an important role in lubrication, cell differentiation and cell growth
Esoxx One is characterised by its protective mucoadhesive effect, prolonging the action of the active substances and promoting healing. It provides rapid and effective relief from the pain of gastroesophageal reflux disease.
DOSAGE AND PRECAUTIONS FOR USE OF ESOXX ONE
Esoxx One is a gel packaged in 10 ml single-dose sachets.
Its usual dosage is 1 sachet to be taken after the main meals and before bedtime.
It has a pleasant taste of red grape.
It is advisable to take Esoxx One at a distance from any other medication